{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihrzr4qwdl4mnpez5ljhphucdwoy56i2r5ptomz74lmuojhlpnfaa",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mgcoycxhj3j2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihkawzmnslrhtds3gzdjcqkntnetbbqdizwfu2dxnnj2dp4ngolbq"
    },
    "mimeType": "image/jpeg",
    "size": 107136
  },
  "path": "/news/2026-03-twenty-percent-eligible-youth-glp.html",
  "publishedAt": "2026-03-04T20:40:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Twenty percent of potentially eligible youth are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs), with the odds of prescription higher with increasing age, increasing body mass index (BMI), and non-Hispanic White or Hispanic race and ethnicity, according to a study published online March 2 in Pediatrics.",
  "title": "Twenty percent of eligible youth prescribed GLP-1 receptor agonists"
}